Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CO/Denver
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Denver, CO

Studies commonly pay $75 to $4,500 per completed study

1,600 clinical trials are currently recruiting participants within 30 miles of Denver. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,600studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Denver right now

Top 25 of 1,600 recruiting studies, sorted by proximity — each links to its official registry page

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Phase 1, Phase 2 Interventional 45 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi) · Sponsor: University of Colorado, Denver

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi) · Sponsor: Nationwide Children's Hospital

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Neuromyelitis Optica Spectrum Disorder, Pregnancy Related N/A Observational 60 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi) · Sponsor: Amgen

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi) · Sponsor: National Cancer Institute (NCI)

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Locally Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 30 participants sought
SCRI Denver Drug Development Unit — Denver, Colorado (6.0 mi) · Sponsor: Acepodia Biotech, Inc.

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Denver, Colorado (6.0 mi) · Sponsor: Dren Bio

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
Children's Hospital of Colorado — Aurora, Colorado (3.2 mi) · Sponsor: St. Jude Children's Research Hospital

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Epithelioid Hemangioendothelioma (EHE) Phase 2 Interventional 41 participants sought
University of Colorado — Aurora, Colorado (3.2 mi) · Sponsor: Sarcoma Alliance for Research through Collaboration

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis N/A Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (6.0 mi) · Sponsor: University of Colorado, Denver

Mode of Exercise and Bone Biomarkers in Older Veterans

Aging, Musculoskeletal Diseases N/A Interventional 120 participants sought
Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado (3.2 mi) · Sponsor: VA Office of Research and Development

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Phase 2 Interventional 38 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi) · Sponsor: Nationwide Children's Hospital

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma Phase 2 Interventional 52 participants sought
Colorado Blood Cancer Institute — Denver, Colorado (6.0 mi) · Sponsor: Irene Ghobrial, MD

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes N/A Observational 200 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi) · Sponsor: Jaeb Center for Health Research

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Rocky Mountain Cancer Centers (RMCC) ( Site 8001) — Aurora, Colorado (3.2 mi) · Sponsor: Merck Sharp & Dohme LLC

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Aurora, Colorado (3.2 mi) · Sponsor: Sameek Roychowdhury

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Barbara Davis Center for Childhood Diabetes — Aurora, Colorado (3.2 mi) · Sponsor: Medtronic MiniMed, Inc.

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection Phase 2 Interventional 84 participants sought
University of Colorado at Denver ( Site 0108) — Aurora, Colorado (3.2 mi) · Sponsor: Merck Sharp & Dohme LLC

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

HIV-1-infection, Frailty Phase 2 Interventional 100 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (3.2 mi) · Sponsor: Massachusetts General Hospital

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

IgA Nephropathy Phase 2 Interventional 25 participants sought
Clinical Research Site 330 — Denver, Colorado (6.0 mi) · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Actively enrolling

Studies you may be able to join near Denver

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for heart failure

This study is enrolling adults in eligible areas of the United States who have been diagnosed with heart failure. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Denver

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

CPC Clinical Research & Community Health

★ 4.0
2115 N Scranton St Ste 2040, Aurora, CO 80045
(303) 860-9900
"We are truly blessed to be apart of their patients. My son sees the Hematology office here and since we are newer to this diagnosis and health condit…"
— Missy R., 5★

Colorado Clinical and Translational Sciences Institute (CCTSI) – Anschutz Medical Campus

1890 N Revere Ct, Aurora, CO 80045
(303) 724-1222

Tekton Research

★ 5.0
2373 Central Park Blvd Unit 300, Denver, CO 80238
(303) 970-9777
"I had excellent experiences during both of the studies I participated in. Both Jessica and Dr. Davidson are thoughtful, thorough and professional but…"
— Karstyn Butler, 5★

Denver Research Institute

3401 Quebec St #5000, Denver, CO 80207
(720) 457-0670

Mountain View Clinical Research

★ 4.3
3955 E Exposition Ave #104, Denver, CO 80209
(720) 941-9363
"Such a great organization with helpful, knowledgeable staff!"
— Windsong Forrest, 5★

Centennial Clinical Trials

469 S Cherry St #101, Denver, CO 80246
(720) 961-1952

Gates Institute

★ 5.0
Mailstop L606, 1890 N Revere Ct, Aurora, CO 80045
(303) 724-1274

Advanced Research Institute - Denver

★ 5.0
1830 Franklin St Ste 220, Denver, CO 80218
(303) 353-2660

Sussel Lab

1775 Aurora Ct, Aurora, CO 80045
(303) 724-9119

Clinical trials in Denver: what's recruiting

The Denver area currently has 1,600 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Denver, the most active research areas are:

  • Cancer & Oncology12 studies
  • Diabetes & Metabolism4 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Denver, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Denver

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Denver participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Denver pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Denver safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Denver, CO?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Denver?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Denver.

Paid clinical trials near Denver

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CO

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts